Full Sail Capital’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,542
Closed -$206K 152
2023
Q2
$206K Hold
2,542
0.02% 144
2023
Q1
$202K Buy
+2,542
New +$180K 0.02% 141
2020
Q3
Sell
-14,460
Closed -$467K 152
2020
Q2
$467K Sell
14,460
-14
-0.1% -$447 0.07% 98
2020
Q1
$454K Sell
14,474
-296
-2% -$8.81K 0.08% 98
2019
Q4
$468K Sell
14,770
-172
-1% -$4.76K 0.1% 106
2019
Q3
$430K Buy
14,942
+32
+0.2% +$809 0.1% 110
2019
Q2
$375K Sell
14,910
-538
-3% -$13.3K 0.11% 103
2019
Q1
$404K Buy
+15,448
New +$380K 0.13% 95

Other funds holding NVO

Full Sail Capital's NVO Position: Q3 2023 in Review

Full Sail Capital sold out of Novo Nordisk (NVO) in Q3 2023, closing a stake of 2,542 shares — an estimated $206K sold.

Full Sail Capital first reported a position in NVO in Q1 2019 and held it in 8 quarters. The position peaked at $468K in Q4 2019. 1,307 funds tracked by Wall St. Rank hold NVO as of Q3 2023.

  • Full Sail Capital reported no remaining Novo Nordisk position as of Q3 2023 after selling out during the quarter.
  • Full Sail Capital sold 2,542 Novo Nordisk shares in Q3 2023, an estimated $206K.
  • Full Sail Capital first reported a position in Novo Nordisk in Q1 2019 and held it in 8 quarters.
  • Full Sail Capital's Novo Nordisk position peaked at $468K in Q4 2019.
  • 1,307 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2023.

Based on Full Sail Capital's 13F filing for Q3 2023, filed 13 Nov 2023.